Abstract
To assess the impact and cost-effectiveness of offering population genomic screening to all young adults in Australia to detect heterozygous familial hypercholesterolemia (FH), hereditarian breast and ovarian cancer and Lynch Syndrome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have